Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Tobacco Prevention & Cessation|June 1, 2026
Tobacco use perceptions and intentions to abstain among adolescents in the English-speaking Caribbean: A cross-sectional secondary analysisRita O Chukwu, Maryam Hadi, Ava G Reynolds, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 17, 2021
Doylestown Plus and GALAD Demonstrate High Sensitivity for HCC Detection in Patients With CirrhosisAmit G Singal, Nabihah Tayob, Anand Mehta, et al.Hepatology (Baltimore, Md.)|October 7, 2021
GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosisAmit G Singal, Nabihah Tayob, Anand Mehta, et al.Journal of the American College of Surgeons|December 4, 2023
Axillary Nodal Response to Neoadjuvant T-DM1 Combined with Pertuzumab in a Prospective Phase II Multi-Institution Clinical TrialAnna Weiss, Qingchun Jin, Adrienne G Waks, et al.Hepatology (Baltimore, Md.)|June 20, 2024
HES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United StatesHashem B El-Serag, Qingchun Jin, Nabihah Tayob, et al.Journal of Hepatology|October 3, 2025
HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohortHashem B El-Serag, Camden Lopez, Michelle Luster, et al.JCO Oncology Practice|May 16, 2023
Identifying Patterns and Barriers in OncotypeDX Recurrence Score Testing in Older Patients With Early-Stage, Estrogen Receptor-Positive Breast Cancer: Implications for Guidance and ReimbursementDario Trapani, Qingchun Jin, Caroline C Block, et al.JAMA Oncology|June 23, 2022
Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast CancerPaolo Tarantino, Qingchun Jin, Nabihah Tayob, et al.Hepatology Communications|February 23, 2026
Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosisAmit G Singal, Qingchun Jin, Jorge Marrero, et al.European Journal of Cancer (Oxford, England : 1990)|September 18, 2022
HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implicationsPaolo Tarantino, Samuel M Niman, Timothy K Erick, et al.Pageof 2